Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maureen Higgins

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
Scientific Reports|August 20, 2025
Chalcone constituents pulincisones A-F isolated from Pulicaria incisa with NQO1 inducer activityAhmed R Hamed, Tarik A Mohamed, Sally A Abdel-Halim, et al.
Biochemical and Biophysical Research Communications|June 22, 2025
CD5L is a target of transcription factor Nrf2Sharadha Dayalan Naidu, Abel D Ang, Charlotte Lim Jia Yee, et al.
Cancer Prevention Research (Philadelphia, Pa.)|March 26, 2015
Nrf2 Activation Protects against Solar-Simulated Ultraviolet Radiation in Mice and HumansElena V Knatko, Sally H Ibbotson, Ying Zhang, et al.
Redox Biology|May 5, 2026
Development of a high-throughput screening platform for identification of functional BACH1 inhibitors reveals compounds with anti-invasive potentialKevin X Ali, Donika Klenja-Skudrinja, Maureen Higgins, et al.
Redox Biology|March 21, 2022
The synthetic triterpenoids CDDO-TFEA and CDDO-Me, but not CDDO, promote nuclear exclusion of BACH1 impairing its activityLaura Casares, Rita Moreno, Kevin X Ali, et al.
Cancer Cell|May 6, 2008
Discovery, in vivo activity, and mechanism of action of a small-molecule p53 activatorSonia Lain, Jonathan J Hollick, Johanna Campbell, et al.
Iscience|February 24, 2022
Nrf2 activation reprograms macrophage intermediary metabolism and suppresses the type I interferon responseDylan G Ryan, Elena V Knatko, Alva M Casey, et al.
Molecular Neurodegeneration|November 4, 2025
M102 activates both NRF2 and HSF1 transcription factor pathways and is neuroprotective in cell and animal models of amyotrophic lateral sclerosisAmy F Keerie, Raquel Rua Martins, Chloe F Allen, et al.
Nature|March 29, 2018
Itaconate is an anti-inflammatory metabolite that activates Nrf2 via alkylation of KEAP1Evanna L Mills, Dylan G Ryan, Hiran A Prag, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 24, 2017
KEAP1-modifying small molecule reveals muted NRF2 signaling responses in neural stem cells from Huntington's disease patientsLuisa Quinti, Sharadha Dayalan Naidu, Ulrike Träger, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Scientific Reports|August 20, 2025
Chalcone constituents pulincisones A-F isolated from Pulicaria incisa with NQO1 inducer activityAhmed R Hamed, Tarik A Mohamed, Sally A Abdel-Halim, et al.
Biochemical and Biophysical Research Communications|June 22, 2025
CD5L is a target of transcription factor Nrf2Sharadha Dayalan Naidu, Abel D Ang, Charlotte Lim Jia Yee, et al.
Cancer Prevention Research (Philadelphia, Pa.)|March 26, 2015
Nrf2 Activation Protects against Solar-Simulated Ultraviolet Radiation in Mice and HumansElena V Knatko, Sally H Ibbotson, Ying Zhang, et al.
Redox Biology|May 5, 2026
Development of a high-throughput screening platform for identification of functional BACH1 inhibitors reveals compounds with anti-invasive potentialKevin X Ali, Donika Klenja-Skudrinja, Maureen Higgins, et al.
Redox Biology|March 21, 2022
The synthetic triterpenoids CDDO-TFEA and CDDO-Me, but not CDDO, promote nuclear exclusion of BACH1 impairing its activityLaura Casares, Rita Moreno, Kevin X Ali, et al.
Cancer Cell|May 6, 2008
Discovery, in vivo activity, and mechanism of action of a small-molecule p53 activatorSonia Lain, Jonathan J Hollick, Johanna Campbell, et al.
Iscience|February 24, 2022
Nrf2 activation reprograms macrophage intermediary metabolism and suppresses the type I interferon responseDylan G Ryan, Elena V Knatko, Alva M Casey, et al.
Molecular Neurodegeneration|November 4, 2025
M102 activates both NRF2 and HSF1 transcription factor pathways and is neuroprotective in cell and animal models of amyotrophic lateral sclerosisAmy F Keerie, Raquel Rua Martins, Chloe F Allen, et al.
Nature|March 29, 2018
Itaconate is an anti-inflammatory metabolite that activates Nrf2 via alkylation of KEAP1Evanna L Mills, Dylan G Ryan, Hiran A Prag, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 24, 2017
KEAP1-modifying small molecule reveals muted NRF2 signaling responses in neural stem cells from Huntington's disease patientsLuisa Quinti, Sharadha Dayalan Naidu, Ulrike Träger, et al.
Pageof 6